SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Cost-Effectiveness Approach To Drug Subsidy And Pricing In Australia
3 references·2 citing·23 second hop
A Cost-Effectiveness Approach To Drug Subsidy And Pricing In Australia (2001)A Cost-Effectiveness Approach To Drug Sub…Cost-Effectiveness Analysis and the Consistency of Decision Making (2001)Cost-Effectiveness Analysis a…The Pharmaceutical Industry — To Whom is It Accountable? (2000)The Pharmaceutical Industry —…Problems With the Interpretation of Pharmacoeconomic Analyses (2000)Problems With the Interpretat…Time dependence in joint replacement to multi-products grouped. The case of hospital food service (2016)Time dependence in joint repl…Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals (2006)Impact of a generic substitut…Payment Restrictions for Prescription Drugs under Medicaid (1987)The role of economic evaluation in the pricing and reimbursement of medicines (1997)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance (2010)Forecasting drug utilization and expenditure in a metropolitan health region (2010)Economics of coronary artery bypass grafting. (1985)Setting Health Care Priorities in Oregon (1991)One Thousand Health-Related Quality-of-Life Estimates (2000)Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES (2003)Assessing the economic challenges posed by orphan drugs (2007)Pricing and reimbursement of orphan drugs: the need for more transparency (2011)Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Cost-Effectiveness in Health and Medicine (1996)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle (2004)Common Methodological Flaws in Economic Evaluations (2005)The Role of Value for Money in Public Insurance Coverage Decisions for Drugs in Australia: A Retrospective Analysis 1994-2004 (2008)Evaluating Density Forecasts with Applications to Financial Risk Management (1998)Lectures on Stochastic Programming: Modeling and Theory (2009)Lectures on Stochastic Programming: Modeling and Theory, Second Edition (2014)Comment on ???The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development??? (2005)The Common Drug Review: A NICE start for Canada? (2005)Prices & availability of common medicines at six sites in India using a standard methodology. (2007)
this work references cited by second hop

References

  • 2001Cost-Effectiveness Analysis and the Consistency of Decision Making431 cited
  • 2000Problems With the Interpretation of Pharmacoeconomic Analyses224 cited
  • 2000The Pharmaceutical Industry — To Whom is It Accountable?164 cited

Cited by

  • 2006Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals85 cited
  • 2016Time dependence in joint replacement to multi-products grouped. The case of hospital food service15 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work